Ocasio, J., Meidinger, J., & Gershon, T. (2017). MEDU-31. GSK-3 PROMOTES PROLIFERATION DURING POSTNATAL CEREBELLAR DEVELOPMENT AND MAY BE TARGETED IN MEDULLOBLASTOMA THERAPY. Neuro Oncol.
Chicago Style aipamenaOcasio, Jennifer, Jessica Meidinger, and Timothy Gershon. "MEDU-31. GSK-3 PROMOTES PROLIFERATION DURING POSTNATAL CEREBELLAR DEVELOPMENT AND MAY BE TARGETED IN MEDULLOBLASTOMA THERAPY." Neuro Oncol 2017.
MLA aipamenaOcasio, Jennifer, Jessica Meidinger, and Timothy Gershon. "MEDU-31. GSK-3 PROMOTES PROLIFERATION DURING POSTNATAL CEREBELLAR DEVELOPMENT AND MAY BE TARGETED IN MEDULLOBLASTOMA THERAPY." Neuro Oncol 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.